OUR PRODUCTS

MOBILE APPS

GENERAL INFO

ABVX

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Abivax SA (ABVX) Earnings Date & Reports

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body’s natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

ABVX is expected to report earnings to fall 29.86% to -68 cents per share on September 08

Q2'25

Est.

$-0.68

Q1'25

Missed

by $0.29

Q4'24

Beat

by $0.50

Q3'24

Beat

by $0.07

Q2'24

Beat

by $0.25

The last earnings report on June 02 showed earnings per share of -96 cents, missing the estimate of -68 cents. With 237.63K shares outstanding, the current market capitalization sits at 5.33B.

View a ticker or compare two or three

Compare

ABVX

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For ABVX
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. ABVX showed earnings on June 02, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

7-11 boulevard Haussmann

Phone

+33 153830963

Employees

Web

https://www.abivax.com